Development of doxycycline-eluting delivery systems based on SynBiosys biodegradable multi-block copolymers.
Gillissen
M
M
Medtronic Bakken Research Center, S&T Biomaterials Technology, Maastricht, The Netherlands. mirian.gillissen@medtronic.com <mirian.gillissen@medtronic.com>
Steendam
R
R
van der Laan
A
A
Tijsma
E
E
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry*; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry*; D003692:Delayed-Action Preparations; D004318:Doxycycline / Q000008:administration & dosage / Q000737:chemistry*; D016503:Drug Delivery Systems / Q000379:methods*; D008863:Microspheres; D011091:Polyesters / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry*; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000737:chemistry; D011100:Polyglycolic Acid / Q000008:administration & dosage / Q000737:chemistry
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; D003692:Delayed-Action Preparations; D011091:Polyesters; C016240:polycaprolactone; D011100:Polyglycolic Acid; D011092:Polyethylene Glycols; C033616:poly(lactide); D004318:Doxycycline